A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus
Description
The circulating flu viruses merging with the ongoing COVID-19 pandemic raises a more severe threat that promotes the infectivity of SARS-CoV-2 associated with higher mortality rates. Here, we conjugated recombinant receptor binding domain (RBD) of